Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Fenretinide in Healthy Young Women at Genetic and Familial Risk

This study has been terminated.
(very low rate of patient accrual)
Information provided by (Responsible Party):
European Institute of Oncology Identifier:
First received: November 22, 2011
Last updated: January 21, 2016
Last verified: December 2015
No Study Results Posted on for this Study
  Study Status: This study has been terminated.
  Estimated Study Completion Date: December 2024
  Estimated Primary Completion Date: December 2024 (Final data collection date for primary outcome measure)